Published January 15, 2026 · Parkinson's Lawsuit Help
Pennsylvania state court claimants are widely expected to recover more, on average, than federal MDL claimants. Three reasons: (1) Pennsylvania's consent-by-registration jurisdiction law — upheld after the U.S. Supreme Court declined to hear Syngenta's challenge in October 2025 — permits suits in Pennsylvania even against foreign defendants who registered to do business in the state; (2) Philadelphia juries have a long track record of higher verdicts in pharmaceutical and toxic tort cases than typical federal MDL bellwethers; and (3) the Philadelphia Complex Litigation Center moves cases on a faster trial schedule than the MDL, which gives plaintiffs leverage in settlement negotiations. This piece walks through what that advantage looks like in practice — and how to know whether your case qualifies for Pennsylvania jurisdiction.
Consent by registration
Pennsylvania's long-arm statute treats a foreign corporation's registration to do business as consent to general personal jurisdiction in Pennsylvania courts. The U.S. Supreme Court declined to review Syngenta's challenge to this doctrine in October 2025. The practical result: claimants exposed in many states can sue Syngenta in Pennsylvania.
Philadelphia Complex Litigation Center
The Philadelphia Court of Common Pleas operates a Complex Litigation Center that handles mass torts under specialized case management orders. Cases move on a faster schedule than the average federal MDL, with regular status conferences and trial-ready postures.
Jury composition and award history
Philadelphia juries have a long history of robust plaintiff verdicts in pharmaceutical and toxic tort cases — Risperdal, Xarelto, and others. Defendants know this, which is why the January 2026 paraquat bellwether settled on the courthouse steps.
Statute of limitations
Pennsylvania applies a two-year statute of limitations for personal injury claims, subject to the discovery rule. Cases involving long-latency diseases like Parkinson's often accrue when the connection between exposure and diagnosis becomes reasonably knowable.
Checking eligibility
If you were exposed to paraquat — anywhere in the United States — and you have been diagnosed with Parkinson's disease, your case may qualify for Pennsylvania jurisdiction. A free case review will confirm.
Get a free case review
If you or a family member were exposed to paraquat and have been diagnosed with Parkinson's disease, request a free case review. It takes 15 to 30 minutes by phone, costs nothing, and locks in your place while settlement options remain open. Check eligibility or call (717) 724-7503.